Sage Journals: Discover world-class research

Abstract

Clinical relevance:

In contrast to superficial fungal infections, such as dermatophytosis, invasive fungal infections (IFIs) are characterised by penetration of tissues by fungal elements. Disease can spread locally within a region or can disseminate haematogenously or via the lymphatics. The environment is the most common reservoir of infection. Since fungal spores are airborne, indoor cats are also susceptible to IFIs. Some environmental fungi are ubiquitous and present globally, while others are endemic or hyperendemic within specific geographic regions. Zoonotic pathogens include Microsporum canis, Sporothrix schenckii and Sporothrix brasiliensis.

Aim:

In the first of a two-part article series, the approach to the investigation of feline IFIs and oomycoses is reviewed. As well as tips for diagnosis, and information on the ecological niche and distribution of fungal pathogens, the review covers clinical presentation of the most common IFIs, including cryptococcosis, histoplasmosis, blastomycosis, coccidioidomycosis, sporotrichosis, phaeohyphomycosis, aspergillosis and dermatophytic pseudomycetoma, as well as the oomycoses pythiosis, lagenidiosis and paralagenidiosis. In Part 2, the spectrum of activity, mechanisms of action, pharmacokinetic and pharmacodynamic properties and adverse effects of antifungal drugs are reviewed, and the treatment and prognosis for specific IFIs and oomycoses are discussed.

Evidence base:

The review draws on published evidence and the authors' combined expertise in feline medicine, mycology, dermatology, clinical pathology and anatomical pathology.

Keywords

Dimorphic fungal infections phaeohyphomycosis aspergillosis dermatophytic pseudomycetoma pythiosis lagenidiosis

Introduction

The outcome of a fungal infection depends on a complex interplay between the fungal pathogen and the host's immune response. Non-invasive fungal infections are those in which fungal elements are restricted to surface colonisation of the skin, hair, mucosa or airways. By contrast, in invasive fungal infections (IFIs), fungal elements penetrate tissues and can spread locally or by haematogenous and/or lymphatic dissemination. For example, in dermatophytosis, the most common non-invasive mycosis of cats, Microsporum canis infects the stratum corneum of the epidermis, hair shafts and hair follicles. However, occasionally, M canis penetrates the dermis to cause an IFI.¹

Part 1 of this two-part article series describes the general diagnostic approach to cats with suspected IFIs or oomycoses, hereafter termed invasive fungal-like infections (IFLIs). Attention then turns to reviewing clinical features and providing diagnostic tips for the most common IFIs and IFLIs. The fungal pathogen Candida is not reviewed since there have been fewer than 10 cases of invasive candidiasis reported;^2-6 by contrast, non-invasive Candida species infections of the lower urinary tract are moderately frequent.⁷ Algal infections, such as protothecosis, and other IFLIs, such as microsporidiosis and rhinosporidio-sis, are outside the scope of this review.^8-17

Agents of disease

The fungal kingdom is vast and currently includes 19 different phyla.¹⁹ The most common moulds and yeasts that cause IFIs in cats are listed in Table 1. Yeasts are unicellular and reproduce asexually by budding to form a daughter cell, whereas moulds are multi-cellular filaments (hyphae) that reproduce asexually through fragmentation of hyphae or production of asexual spores (conidia). Many yeasts and moulds also reproduce sexually by meiosis. Some yeasts have three vegetative states - yeast, pseudohyphae and hyphae -which can make cytological identification in tissues more difficult. Some fungi (thermally dimorphic ascomycetes, Table 1) exist as moulds in their environmental reservoirs and switch to yeast forms in the higher temperatures of infected hosts.²⁰

Table 1

Classification of common invasive fungal pathogens in cats

Phylum	Class	Genus
Phylum	Class	Hyaline (non-pigmented) hyphomycete moulds	Dematiaceous (pigmented) hyphomycete moulds	Dimorphic fungi
Ascomycota	Eurotiomycetes	Aspergillus species Microsporum species	Cladophialophora species Exophiala species	Histoplasma species^† Blastomyces species^† Coccidioides species^†
	Sordariomycetes		Scedosporium species Lomentospora species	Sporothrix species^†
	Dothideomycetes		Curvularia species Bipolaris species Cladosporium species
Basidiomycota	Tremellomycetes			Cryptococcus species
Mucoromycota*	Mucoromycetes	Rhizopus species Mucor species
Basidiobolomycota*	Basidiobolomycetes	Basidiobolus species
Zoopagomycota*
Entomophthoromycota*	Entomophthoromycetes	Conidiobolus species

Previously known as Zygomycetes. ^†Thermally dimorphic

Oomycetes are the most common fungal-like organisms to infect cats.

Most feline IFIs and IFLIs are not zoonotic. Rather, they are caused by shared environmental pathogens, which lead to disease in humans and animals alike, usually through inhalation or traumatic cutaneous inoculation. Sporotrichosis is a notable, highly zoonotic exception. M canis is also zoonotic in cats with dermatophytic pseudomycetoma and concurrent dermatophytosis.

General diagnostic approach to a possible invasive fungal or fungal-like infection

History and signalment

Knowledge of which fungi are ubiquitous saprophytes, occurring anywhere regardless of geographic location, and which are endemic or hyperendemic in particular regions is helpful when considering the likelihood and ranking of an IFI/IFLI in the differential diagnosis list (Figure 1; see also later discussion of the 'Diagnostic approach for selected invasive fungal and fungal-like infections'). With global warming, the geographic range of many environmental fungi is increasing.²¹ Travel history is also important, because some IFIs (eg, cryptococcosis and histoplasmosis) can be latent and subclinical but can reactivate months to years later if the cat is immunosuppressed.²²

Figure 1

The geographic range of many environmental fungi is increasing in association with global warming and will likely continue to expand.

Patient signalment can raise the ranking of IFI/IFLI on the differential diagnosis list. For example, Persian cats and related breeds are predisposed to some IFIs, including aspergillosis and dermatophytic pseudo-mycetoma.²³ Fungal infections can occur in cats of either sex or any age, but some predispositions exist for certain IFIs/IFLIs (see 'Diagnostic approach for selected invasive fungal and fungal-like infections'). Moreover, while IFIs are commonly diagnosed in apparently immunocompetent cats, immuno-suppression from concomitant disease or immunomodulatory drugs, such as ciclo-sporin,²⁴ is a risk factor for IFIs and also for haematogenous dissemination of an IFI.

Complete blood count, serum biochemistry profile and retrovirus testing

For mould IFIs and IFLIs, an inflammatory leukogram and mild to severe hyperglobuli-naemia are common abnormalities.²⁵ Hyper-globulinaemia is present in ~65% of cases of sporotrichosis.²⁶

Mild to moderate non-regenerative anaemia (normocytic, normochromic) is common in cats with cryptococcosis, sporotrichosis and histoplasmosis, but anaemia may be severe in cats with histoplasmosis.^26-29 Leukocyte changes are variable among infections caused by thermally dimorphic fungi. Neutrophilic leukocytosis, sometimes with a left shift, is common in both histoplasmosis and sporo-trichosis,^26,28 while monocytosis is a common finding in cases of cryptococcosis²⁷ and coccidioidomycosis.³⁰ Infiltration of bone marrow in cats with disseminated histoplasmosis may result in neutropenia, thrombocytopenia or pancytopenia.³¹

Peripheral eosinophilia is not common overall, but, if present, should raise a flag for possible IFIs/IFLIs of any type. Hypoalbuminaemia is common in disseminated sporotrichosis and histoplasmosis,²⁶ especially where there is gut involvement. Hypercalcaemia may be present due to monocyte and macrophage activation within pyogranulomas; increased expression of 25-hydroxyvitamin D₃ 1a-hydroxylase then results in hypervitaminosis D. This has been reported in histoplasmosis, blastomycosis and dermatophytic pseudomycetoma.^28,32,33 Other serum biochemical changes in IFIs/IFLIs reflect specific organ involvement.

Results of feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) testing reflect regional prevalence, and, although these retroviruses are not significantly associated with IFIs/IFLIs, testing is recommended. A positive test result is not a contraindication for IFI/IFLI treatment; however, cats with advanced FIV or FeLV infection may require longer courses of treatment.

Fungal-specific tests on urine, serum or other body fluids

Serum antibody or fungal antigen tests, as listed in Table 2, are especially useful in the early stages of a diagnostic investigation since test samples can mostly be procured without the need for general anaesthesia. Their use should be guided by the patient's clinical signs at presentation, as well as the travel history and geographic location. Aspergillosis and crypto-coccosis occur worldwide. While sporadic cases of histoplasmosis and sporotrichosis may also be seen in any geographic region, these, as well as blastomycosis, coccidioidomycosis and pythiosis, usually occur in endemic/hyper-endemic regions (Figure 1). Tests to detect fungal antibodies or antigens in serum or urine are not currently available for dermatophytic pseudomycetoma or phaeohyphomycosis.

Table 2

Availability of antibody and antigen tests for invasive fungal and fungal-like infections in cats

Aspergillosis	Sporotrichosis	Histoplasmosis	Blastomycosis	Coccidioidomycosis	Cryptococcosis	Pythiosis
SERUM ANTIBODY
✓	✓	✘	✘	✓	✘	✓
✜ ELISA: >90% Se and Sp,^34,35 but limited/no commercial availability ✜ AGID: 43% Se, >90% Sp³⁴	✜ ELISA: >90%Se and Sp, but limited/no commercial availability³⁷	✜ AGID and CF: low Se and Sp; no rigorous studies s studies	✜ RIA and EIA: commercialavailability fordogs only ✜ AGID: ~20%Se; notrecommended	✜ AGID: two tests - one to detect antibodies (IgG and IgM), the otherto quantitate IgG byserial dilution of positivesera.⁴¹ High Se (43/44cats³⁰ and 39/39 cats⁴¹in two studies); Sp unknown. A positive titre indicates previousor active infection.A sick cat withconsistent clinical signsand positive serologylikely has activeinfection⁴²		✜ ELISA: limitedSe and Sp dataavailable, but likelysimilar to dogs withpythiosis - that is,high Se andmoderate Sp⁴⁶
FUNGAL ANTIGEN
✘	✘	✓	✓	✘	✘	✘
✜ Sample: serum ✜ Detects: serum GM✜ EIA: 23% Se, 78% Sp; notrecommended³⁶		✜ Sample: urine(best), serum,BAL fluid✜ Detects:Histoplasmacapsulatum antigen ✜ EIA: >90% Se and Sp (urine).^38,39in localisedMay be negativeinfections.⁴⁰ HighSp for fungal vsnon-fungal disease(~97%), but low Spfor fungal genus dueto cross-reactivitywith other fungi,especiallyBlastomyces species	✜ Sample: urine(best), serum ✜ Detects:fungal cell wallantigen (GM)also present inother fungal species✜ EIA: 87% Se(serum), 94% Se(urine). Sp is lowbecause ofcross-reactivitywith other fungi,especiallyHistoplasmaspecies	✜ Sample: serum, urine✜ Detects: Coccidioides speciesGM antigen. Notevaluated in cats but notrecommended in dogs due to low Se (~20%)⁴³	✜ Sample:serum,CSF✜ Detects:polysaccharidecapsule antigen✜ CALAS: >90%Se and Sp⁴⁴✜ POC LFA test:80-92% Se,>90% Sp.⁴⁵May be negativein localisedinfections. False-positive resultsmore likely at lowtitres

AGID = agar gel immunodiffusion; BAL = bronchoalveolar lavage; CALAS = cryptococcal antigen latex agglutination system; CF = complement fixation; CSF = cerebrospinal fluid; EIA = enzyme immunoassay; ELISA = enzyme-linked immunosorbent assay; GM = galactomannan; POC LFA = point-of-care lateral flow antigen; RIA = radioimmunoassay; Se = sensitivity; Sp = specificity

Diagnostic imaging

Table 3

Typical radiographic findings in invasive fungal and fungal-like infections in cats

Phaeohyphomycosis	Aspergillosis	Sporotrichosis	Histoplasmosis
✜ Skull: usually normal ✜ Thorax: may be abnormal if there is haematogenous dissemination. Changes may include pulmonary mass(es)⁴⁷	✜ Skull: may be abnormal ✜ Thorax: usually normal in SOA, abnormal in invasive pulmonary aspergillosis and may be abnormal in DIA. Changes are not well characterised but may be similar to other causes of fungal pneumonia (eg, histoplasmosis, blastomycosis)	✜ Skull: may be abnormal ✜ Thorax: generally normal. May be abnormal (pulmonary infiltrates) in disseminated disease; changes are not well described ✜ Appendicular: lesions on the limbs are not usually associated with underlying bone or joint involvement	✜ Skull: usually normal ✜ Thorax: abnormal in up to 50% of cases - diffuse, linear, nodular or miliary interstitial infiltrates.^31,50 Mixed patterns (bronchointerstitial/alveolar) and pleural effusions can also occur ✜ Appendicular: synovial effusions, pathological fractures, multifocal lytic metaphyseal lesions and proliferative periosteal reactions commonly affect more than one long bone/joint; carpus and tarsus frequently involved^28,29
Blastomycosis	Coccidioidomycosis	Cryptococcosis	Oomycosis
✜ Skull: usually normal ✜ Thorax: usually abnormal, even in the absence of respiratory signs. Poorly defined soft tissue pulmonary masses, nodules or alveolar consolidation are most common. Also miliary interstitial infiltrates, cranial mediastinal mass and/or hilar masses⁴⁸	✜ Skull: usually normal ✜ Thorax: often abnormal, even in the absence of respiratory signs. Diffuse mixed pattern (alveolar/ bronchial/interstitial) consolidation is common; other findings may include hilar lymphadenopathy, pleural effusion, lobar consolidation and/or mass/nodule³⁰ ✜ Appendicular: lytic and proliferative lesions with periosteal new bone formation (fungal osteomyelitis)³⁰	✜ Skull: may be abnormal ✜ Thorax: usually normal in cats with Cryptococcus neoformans species complex infection. Abnormal in up to 40% with Cryptococcus gattii species complex infection. Diffuse, regional, nodular or occasionally miliary interstitial infiltrates, alveolar infiltrates, mediastinal mass, hilar masses and/or pleural effusion⁴⁹ ✜ Appendicular: lesions on the limbs are not usually associated with underlying bone or joint involvement	✜ Skull: may be abnormal ✜ Thorax: usually normal ✜ Appendicular: usually normal

DIA = disseminated invasive aspergillosis; SOA = sino-orbital aspergillosis

Thoracic radiography is useful when an IFI/ IFLI is suspected because the respiratory tract is the most common portal of entry and may be diseased. A predilection for upper or lower respiratory tract involvement, or both, depends on the infecting pathogen (Table 3). Because of the superimposition of anatomical structures, skull radiography is not sensitive for the detection of upper respiratory tract involvement; if suspected, CT examination of the head is recommended. CT changes in sino-orbital aspergillosis (SOA) may include increased soft tissue attenuation of the nasal cavities and sinuses, as well as turbinate lysis.⁵¹ The degree of nasal cavity involvement ranges from mild to severe. Orbital masses are usually unilateral and ven-tromedial, with heterogeneous and peripheral rim contrast enhancement. Changes in thesinonasal cavity, orbit and paranasal bones are not specific for aspergillosis and may be indistinguishable from neoplasia (eg, nasal carcinoma or lymphoma) or other IFIs/IFLIs such as cryptococcosis,²³ sporotrichosis or pythiosis.⁵² If neurological signs are present, MRI of the head or spinal cord (depending on lesion localisation) is the preferred imaging modality. In SOA, orbital masses are hyperintense and heterogeneous on T1- and T2-weighted images, and enhance with con-trast.^53-55 If present, central nervous system (CNS) lesions show increased heterogeneous contrast enhancement. In blastomycosis with CNS involvement, there are focal or multifocal intra-axial masses with dural contact; lesions are hypointense on T2-weighted images and diffusion-weighted imaging, and show severe perilesional oedema and strong homogeneous contrast enhancement.⁵⁶ In disseminated phaeohyphomycosis with CNS involvement, there may be focal or multifocal fungal abscesses; MRI features of these lesions in humans - which are likely similar in cats -include irregular walls and intracavitary projections caused by fungal hyphae.⁵⁷ Fungal granulomas in cases of cryptococcosis are hypointense on T1- and hyperintense on T2-weighted images, often with well-defined rim enhancement after contrast administration.^58,59

Advanced imaging is not reliable for definitive diagnosis of fungal granulomas since, for both CT and MRI, features overlap with those of neoplasia.^23,51,58,60

DIA = disseminated invasive aspergillosis; SOA = sino-orbital aspergillosis

Cytology

Cytology of fine-needle aspirates from masses, cytocentrifugation (cytospin) preparations of urine, bronchoalveolar (BAL) fluid, cerebrospinal fluid (CSF), brushings from conjunc-tivae or impression smears of ulcerated lesions can provide useful information. Fungal elements, if present, can usually be identified using Romanowsky-type stains, such as Wright, Giemsa and Diff-Quik. Depending on the pathogen, fungal elements may exhibit positive or negative staining (Figure 2). Additional tissue or fluid samples obtained aseptically for cytology can also be submitted for fungal culture to confirm pathogen identity and antifungal susceptibility.

Figure 2

Diff-Quik stained smears showing fungal elements. (a) Positive-staining fungal hyphae in frontal sinus tissue of a cat with invasive fungal rhinosinusitis due to Aspergillus felis infection. (b) Intracellular negative-staining fungal elements in a fine-needle aspirate preparation from a retrobulbar mass of a cat with a phaeohyphomycosis caused by Phoma species

In general, cytology or culture of nasal swabs or washes cannot be used for definitive diagnosis since the nasal cavity can be contaminated with or colonised by fungal spores, which can readily be cultured, giving rise to a false-positive diagnosis of fungal infection. However, if large numbers of fungal elements (hyphae, yeasts) are visualised in the presence of inflammatory cells, there should be a high index of suspicion for fungal infection and a confirmatory test should be performed (eg, fungal antigen test or biopsy).

Surgical biopsies: procurement and transport to the laboratory

Surgical biopsies of involved tissues are often the best samples for definitive diagnosis, especially where less invasive (eg, antigen) tests are not available or where cytology is non-diagnostic. Definitive diagnosis is dependent on taking a representative biopsy of tissue. In many IFIs/IFLIs, fungal elements are only found in the necrotic centre of pathological lesions and are surrounded by a pyogranulomatous inflammatory reaction, which may contain a large proportion of eosinophils. Biopsies that sample only the periphery of a granuloma may yield negative fungal cultures, leading to a misdiagnosis on histology of eosinophilic granuloma complex or non-fungal sterile inflammation. The authors have observed this in cases of SOA and dermatophytic pseudomycetoma.

When performing surgical tissue biopsy from a cat with a possible IFI/IFLI, a good general rule of thumb is either to take one large biopsy and divide it into three portions, or to take three smaller individual representative biopsies. One sample (or portion) is placed in formalin, one is placed in sterile saline in a sterile container for culture and the remaining one is placed in a sterile container and frozen for later molecular diagnostics if fungal culture is negative (Figure 3). Hyphae can be damaged in tissue samples that are homogenised in the laboratory using tissue grinding or beads, as is common practice for bacterial culture, resulting in negative mould cultures.⁶¹ The recommended technique for preparing tissues in the laboratory for fungal culture is to dice them into small (2 mm³) pieces using a sterile scalpel blade. Yeasts are less likely to be damaged by homogenisation than moulds.

Figure 3

Representative tissue biopsies from a lesion (A) are placed in formalin (Bi) for histopathology, in sterile saline in a sterile container (Ci) for culture or in a sterile container (D) for frozen storage at -20°C. After embedding formalin-fixed samples in a paraffin block, a microtome (Bii) is used to cut thin sections for histological examination (Biii[a]). If fungal elements are identified on histology and fungal culture is negative, 6-10 urn thick formalin-fixed sections are cut from the paraffin block using the microtome and a sterile blade, and then placed in a sterile tube (Biii[b]) for DNA extraction and molecular identification. Tissue samples should be diced into small pieces (2 mm³) and cultured on fungal agar (Cii[a]). Molecular identification is most reliable using DNA extracted from fungal culture material (Ciii[a]). DNA can also be extracted from residual fresh tissue (Cii[b]) or from stored frozen tissue (D) for molecular identification

Samples for culture should be submitted to the laboratory at room temperature if they can be delivered within 2 h; otherwise, they should be refrigerated at 4°C until collection.⁶²

Some fungal elements are hard to visualise on routine haematoxylin and eosin staining of histological preparations. Whenever fungal infection is suspected by the clinician, additional 'fungal' stains should be requested. This includes all cases in which histological reports of biopsied tissues describe a pyogranulomatous or granuloma-tous inflammatory response but where no fungal elements are detected. The two most common special stains used to detect fungal and fungal-like elements are periodic acid-Schiff and Grocott methenamine silver (Figures 4 -7).

Figure 4

PYTHIOSIS. Histological sections of a skin biopsy sample from a 6-month-old female domestic shorthair cat with a granulating lesion on the right hindlimb. Pythium insidiosum infection was diagnosed within the dermis and subcutis. (a) On haematoxylin and eosin staining, ghost-like outlines of irregular hyphae (arrows) can be seen embedded in the magenta pink necrotic material. On periodic acid-Schiff (b) and Grocott methenamine silver (c) staining, irregular hyphae with non-parallel walls and tapering ends are identified. Bar = 10 um

Figure 5

PHAEOHYPHOMYCOSIS. Histological sections of a skin biopsy sample from an adult domestic shorthair cat with a large ulcerated nodular skin mass. (a) Haematoxylin and eosin-stained section; within the chronic severe pyogranulomatous dermatitis and panniculitis, hyphal elements (3-4 um in width) are easily identified due to their melanised (brown) cell walls. Septate hyphae stain positively with periodic acid-Schiff (b) and Grocott methenamine silver (c). Bar = 10 um

Figure 6

CRYPTOCOCCOSIS. Histological sections from a mass infiltrating the left external ear canal of a 9-year-old female neutered domestic shorthair cat with Cryptococcus neoformans infection. (a) Haematoxylin and eosin-stained section; sheets of refractile, round-to-oval yeasts, occasionally exhibiting narrow-necked budding (arrow), are surrounded by large unstained capsules. Yeast walls stain magenta with periodic acid-Schiff (b) and black with Grocott methenamine silver (c). Bar = 10 um

Figure 7

DERMATOPHYTIC PSEUDOMYCETOMA. Histological sections from a resected nodule from a 10-month-old female neutered Exotic Shorthair cat. The patient had multiple subdermal nodules on the head and abdomen with pyogranulomatous dermatitis and panniculitis due to Microsporum canis infection. (a) Haematoxylin and eosin-stained section; mats of fungal hyphae with occasional bulbous ends are surrounded by neutrophils and a multinucleated giant cell (asterisk). Fungal hyphae stain magenta pink with periodic acid-Schiff (b) and brown/black with Grocott methenamine silver (c). Bar = 10 um

Adequate tissue should be sampled for submission for histology and for fungal culture. In practice, fungal cultures are often not requested at the time of biopsy, either because an IFI/IFLI is not suspected or because of client financial constraints.

Fungal culture

Optimal conditions for culture

The most reliable way of definitively identifying the cause of an IFI is by fungal culture (Table 4). However, it is underutilised in veterinary medicine. Morphological features of fungal colonies and microscopic examination of cultured fungal elements usually enable identification to genus level. Identification to species level may require one or more PCR assays or matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS), using fungal culture material.

Table 4

Optimal media and incubation temperatures for fungal isolation, and targets for PCR of DNA extracted from fungal culture for molecular identification⁶³

Genus or group	Media^*	Optimal growth conditions	Molecular targets for PCR assays
Aspergillus species	MEA, SDA, CzA	28-37°C	ITS1, ITS2 or ITS1-5.8S-ITS2, p-tubulin, calmodulin, actin
Basidiobolus species Conidiobolus species	SDA, IMA, PDA, CMA	30°C and 37°C; faster growth at 30°C. Difficult to grow, especially after prolonged transportation. Killed by refrigeration	ITS1, ITS2 or ITS1-5.8S-ITS2, 18S rRNA, Cyt b
Cryptococcus species	SDA, BSA, CGB	37°C (budding yeast)	ITS1, ITS2 or ITS1-5.8S-ITS2, D1/D2
Histoplasma species	BHIA	25-30°C (mould) 37°C (budding yeast)	ITS1, ITS2 or ITS1-5.8S-ITS2
Mucor species	PDA, CzA, water agar with 0.1% yeast extract	30°C or 37°C (depending on species). Difficult to culture; grinding specimens may damage fragile hyphae	ITS1, ITS2 or ITS1-5.8S-ITS2, Cyt b
Dematiaceous fungi (Phaeohyphomycetes)	SDA, MEA, IMA, PDA	25-37°C	ITS1, ITS2 or ITS1-5.8S-ITS2, actin, GPDH
Microsporum canis (dermatophytic pseudomycetoma)	PDA	25-35°C	ITS1, ITS2 or ITS1-5.8S-ITS2, D1/D2
Pythium species Lagenidium species	SDA, PDA, CMA, blood agar	34-37°C	ITS1, ITS2 or ITS1-5.8S-ITS2, COXII
Sporothrix species	BHIA	25°C and 37°C	ITS1, ITS2 or ITS1-5.8S-ITS2, D1/D2, P-tubulin, chitin synthase, TEF

Non-selective general purpose media are shown in bold

BHIA = brain-heart infusion agar; BSA = bird seed agar; CGB = canavanine glycine bromothymol blue agar; CMA = corn meal agar; Cyt b = cytochrome b gene; CzA = Czapek Dox agar; GPDH = glycerol-3-phosphate dehydrogenase; IMA = inhibitory mould agar; ITS = internal transcribed spacer; MEA = malt extract agar, PDA = potato dextrose agar, SDA = Sabouraud's dextrose agar, TEF = translation elongation factor

The success of fungal culture depends to a large extent on the expertise of the laboratory processing the sample, as well as the condition in which the biopsy is received, and the duration and conditions of transport. Reasons for negative fungal cultures include use of culture media and/or incubation temperatures that are not conducive for growth, as well as overgrowth by commensal or contaminating bacteria or fungi. The use of at least two different incubation temperatures and different types of media has been shown to increase the sensitivity of isolation of fungi from clinical specimens.⁶⁴

It is well worth contacting the diagnostic laboratory to ascertain whether it:

✜ Routinely incubates fungal cultures at two different temperatures: most commonly 25° or 28°C, and 37°C;²⁵

✜ Uses culture media supplemented with antimicrobials (usually gentamicin or chlor-amphenicol) when bacterial contamination of the sample is likely;

✜ Has the capacity to perform molecular testing and/or MALDI-TOF MS;

✜ Submits unusual isolates to a mycology reference laboratory for definitive species identification. Since many of the organisms that cause IFIs/IFLIs in cats are environmental saprophytes capable of infecting humans, mycology reference laboratories are well equipped to identify them.

Most thermally dimorphic species of fungi (eg, Sporothrix species, Histoplasma species) pose an inhalational infection risk to laboratory staff if grown as moulds, and culture of these species is not recommended routinely. If culture is required, laboratory staff should be warned in advance if fungal infection is suspected, as advanced biosafety level (BSL3) conditions to prevent inhalation of spores may be required.

Molecular diagnostics

Many veterinary diagnostic laboratories now offer molecular assays for identification of fungal pathogens. Molecular identification is most reliable when DNA for PCR and sequencing is extracted from fungal cultures of clinical specimens.⁶⁵ Fungal DNA can also be extracted directly from formalin-fixed paraffin-embedded tissue (FFPET) or from fresh or frozen clinical specimens (Figures 3 and 8).⁶⁶ Panfungal PCR primers are used to target part of the ribosomal RNA (rRNA) gene cluster present in multiple copies in yeasts, moulds and oomycetes (Table 4 and Figure 8).⁶⁷

Figure 8

(A) DNA extracted from fungal culture material, formalin-fixed paraffin-embedded tissues or fresh or frozen tissues can be subject to PCR and sequencing to determine fungal genus and species complex or species. (B) The methodology uses panfungal PCR primers to amplify targets within the multicopy ribosomal RNA gene cluster of fungi, which contains hypervariable regions. ITS = internal transcribed spacer; IGS = intergenic spacer

Sequencing the entire ITS1-5.8S-ITS2 region (~700 nucleotides) within the rRNA gene cluster amplified from fungal culture DNA extracts enables identification at least to genus and species complex level (Figure 8).^23,65 DNA extracted from FFPET may be degraded or fragmented and DNA quality is also influenced by the duration of formalin contact and number of fungal elements (hyphae, yeasts) present in the FFPET paraffin block, reducing the sensitivity of PCR assays (Figures 3 and 8). However, amplification of the shorter ITS1 (~290 nucleotides) or ITS2 regions (~330 nucleotides) is often possible.^25,67 In one study, where fungal elements were identified on histology of lesions from animal tissues, ITS2 PCR of FFPET DNA enabled identification to genus level in 65% of samples; in 96% of these, the identified fungus was consistent with the morphological identification on histological examination.⁵⁰

Antifungal susceptibility testing

Broth microdilution methods are the most reliable means of determining in vitro anti-fungal susceptibility. There are two reference methods - one from the Clinical and Laboratory Standards Institute (CLSI) and one from the European Committee on Antimicrobial Susceptibility Testing (EUCAST). Both use a 96-well format, broth media (RPMI 1640) and a minimum inhibitory concentration (MIC) endpoint (ie, complete inhibition of growth determined by visual inspection).

Commercial kits are also available, such as Sensititre YeastOne (TREK Diagnostic Systems), which utilises antifungals in serial two-fold dilutions on a 96-well, dried colori-metric broth microdilution panel. It has shown high interlaboratory reproducibility and moderate to high correlation with the reference methods, dependent on the fungal genus.^68,69

Although clinical MIC breakpoints, which correlate in vitro data (including susceptibility testing results and drug pharmacokinetics/ pharmacodynamics) with clinical trial outcomes, are still lacking in veterinary medicine, these are available for many fungal pathogens in humans and are broadly applicable. Also, epidemiological cut-off values (ECVs) of MICs are useful to detect decreased susceptibility or resistance in vitro. ECVs are upper limit values set by determining the distribution of MICs for wild-type isolates. The wild-type population is most commonly defined as those isolates around the modal MIC ± one two-fold dilution, which encompasses >95% of strains.

Diagnostic approach for selected invasive fungal and fungal-like infections

Cryptococcosis

✜ Aetiological agents Cryptococcus neoformans species complex (C neoformans, C deneoformans), C gattii species complex (C gattii, C deuterogat-tii, C tetragattii, C decagattii, C bacillisporus) and their hybrids.^70,71 Although not truly thermally dimorphic (ie, C neoformans exists as a yeast in pigeon guano), all Cryptococcus species switch to a filamentous form to produce basidiospores during sexual reproduction in the environment.

✜ Ecological niche C neoformans species complex is primarily isolated from pigeon guano and less frequently from organic matter in soil.⁷² C gattii species complex has been found in wood, leaves, bark and plant debris of more than 50 tree species, including Eucalyptus species.⁷³

✜ Geographic distribution The C neoformans species complex is distributed worldwide.⁷² The distribution of the C gattii species complex is illustrated in Figure 1.

✜ Transmission Airborne infectious particles (basidiospores or desiccated yeast cells) are inhaled and deposited in the nasal cavity and/or sinuses. Less frequently, transmission is by ingestion of infectious propagules or inoculation through penetrating skin wounds.⁷⁴

✜ Clinical forms of disease Nasal,²⁷ CNS,⁴² systemic⁷⁵ and cutaneous^76,77 forms of disease are described, but there is considerable overlap between them. Nasal signs may be subtle or absent in CNS and other forms. Both Cryptococcus species complexes can cause all clinical forms of disease.

✜ Clinical presentation Nasal disease - Signs of chronic rhinitis (nasal discharge, sneezing, stertor, variable epistaxis) and mandibular lymphadenopathy are com-mon.²⁷ Progressive osteolysis of the sinonasal cavity can lead to proliferative or ulcerative nasofacial skin and mucosal lesions, and facial deformity. Otitis media and vestibular signs may also occur.⁷⁸ Extension of disease into the lower respiratory tract to cause pneumonia and pleural effusion occurs less commonly.^79,80

CNS disease - Extension of nasal disease through the cribriform plate or haemato-genously can cause ocular involvement (chorioretinitis, optic neuritis, uveitis), meningoencephalomyelitis and/or fungal CNS granulomas. Presentations include behavioural changes, altered mentation, inappetence, sudden-onset blindness, ataxia, spinal pain and seizures.^59,81 Increased intracranial pressure can result in severe acute obtundation.

Systemic and cutaneous disease - Systemic and cutaneous forms of cryptococcosis (Figure 9) signal advanced disease resulting from haema-togenous spread.⁷⁵ Cutaneous lesions include non-pruritic, solitary or multiple nodules, abscesses and/or ulcers, with or without peripheral lymphadenopathy.⁷⁷ Systemic presentations reflect organ involvement, ranging from skeletal (osteomyelitis, arthritis) to multi-organ disease (gastric and intestinal lesions, hepatitis, pancreatitis, renal abscessation, bladder wall infection, adrenal gland granulomas, generalised lymphadenomegaly).

Figure 9

(a,b) A 6-year-old female neutered domestic shorthair cat in Hong Kong with large fleshy subcutaneous masses infiltrating the external ear canal caused by Cryptococcus neoformans. Images courtesy of Dr Edmund Cheung

Histoplasmosis

✜ Aetiological agents Histoplasma capsula-tum (H capsulatum var capsulatum, H capsula-tum var farciminosum, H capsulatum var duboisii).

✜ Ecological niche Soil, bat and bird guano harbour the organisms.⁸³ Organic fertilisers and potted plant soil can also be sources of infection for indoor cats.⁸⁴

✜ Geographic distribution H capsulatum is distributed worldwide, especially in tropical and subtropical regions. Hyperendemic areas include the Ohio/Mississippi River Valleys of South-central and Midwestern USA, Latin America (Figure 1), as well as some parts of Southeast Asia and India.⁸⁵

✜ Transmission Airborne spores (micro-conidia) of the filamentous form are inhaled and deposited in the lungs, before transforming into yeasts.

✜ Clinical forms of disease Pulmonary or disseminated disease is seen, the latter most commonly involving infiltrates in the spleen, liver, bone marrow, eyes and gastrointestinal tract.⁸⁶

✜ Clinical presentation Chronic and disseminated disease is common. Clinical signs are usually non-specific and frequently include lethargy, inappetence, weight loss and peripheral lymphadenomegaly, while fever is variably present.^31,86-88 Respiratory signs may include dyspnoea and/or tachypnoea (affecting ~50-60% of cases).⁸⁹ Cough or nasal discharge is less common.^90,91 Ocular signs, including conjunctivitis, blepharitis (eyelid swelling), chorioretinitis, uveitis and/or optic neuritis, occur in up to 25% of cases.^40,92,93 Musculo-skeletal signs, including lameness and joint effusions, are present in up to 20% of cases.^28,31,89 Less common presenting signs include cutaneous nodules or ulcers (~15% of cases), diarrhoea (~10%), CNS signs (~5%) and/or jaundice.⁸⁹ Clinical examination often identifies peripheral and visceral lymphadenopathy, along with cranial abdominal organomegaly.

Figure 10

Diff-Quik stained smear from the left mandibular lymph node of a cat with cryptococcosis, showing sheets of round yeasts with a non-staining capsule and occasional narrow-necked budding (arrows). An inflammatory response with neutrophils and macrophages is also apparent. x 40 objective

Figure 11

Diff-Quik stained smear from a mesenteric lymph node of a cat with disseminated histoplasmosis, showing numerous intracytoplasmic round yeast forms within macrophages. x 100 objective

Blastomycosis

✜ Aetiological agent Blastomyces dermatitidis.

✜ Ecological niche B dermatitidis is found in soil, especially near waterways in wooded areas in endemic regions. Infection can occur in indoor-only cats.97

✜ Geographic distribution The organism is endemic in the USA, Canada and Africa, especially around the Great Lakes and Ohio/ Mississippi River Valleys (USA), with recent evidence of expansion to New York State and Saskatchewan (Figure 1).⁹⁸

✜ Transmission Airborne conidia (spores), 2-10 |jm in diameter, are inhaled and deposited in the lungs.

✜ Clinical forms of disease Disease may be pulmonary or disseminated.

✜ Clinical presentation Blasto mycosis is uncommon in cats, which are far less susceptible to infection than dogs. The disease is similar in clinical presentation to histoplasmosis, although dermatological involvement is more common and lymphadenomegaly less common.^48,97,99

Coccidioidomycosis

✜ Aetiological agents Coccidioides immitis and Coccidioides posadasii.

✜ Ecological niche Coccidioides species favour warm, arid to semi-arid regions in alkaline, sandy soil, growing especially after rains have abated but soil is still moist.

✜ Geographic distribution Distributed throughout the Americas, especially Arizona (~60% of all reported human cases), central/southern California (35% of cases), Texas, Utah, Nevada and New Mexico (Figure 1), these fungi are becoming more widespread in the USA, with, for example, recent spread to Washington. Isolated case reports of infection in China in people with no travel history to hyperendemic regions are increasing in frequency.^21,100

✜ Transmission Hot, dry conditions result in desiccation of hyphae, and their maturation and fragmentation to become infective arthro-conidia; these are dispersed in air and dust by wind, and inhaled. Arthroconidia may also be transported on fomites to cause infection.

✜ Clinical forms of disease Infections may be respiratory or disseminated, with frequent involvement of skin, eyes, bones/joints, CNS and/or viscera.

✜ Clinical presentation Der ma tological lesions (nodules, non-healing wounds, draining lesions or plaques), especially on the trunk and distal extremities, and/or respiratory signs (chronic cough, respiratory distress) are most common, often accompanied by nonspecific signs (fever, inappetence, anorexia, weight loss). Less commonly, lameness, ocular signs (chorioretinitis, uveitis, panophthal-mitis, retinal detachment) or CNS signs are _reported.^{30,41,42,101,102}

Figure 12

A 5-year-old male neutered domestic longhair cat from Arizona, USA, presented with severe weight loss (50% body weight decline), anorexia, dehydration and progressive hindlimb paralysis. (a) A right lateral thoracic radiograph showed a cranial mediastinal mass (asterisk) and a lytic-proliferative osteomyelitic lesion of the T2 vertebral process (arrow). (b) Lytic and proliferative osteomyelitis of the body and vertebral process of L4, extending along the ventral edges to involve L3 and L5, was causing the paralysis due to compression of the spinal cord at L4. The cat was positive for coccidioidomycosis on serology, with an anti-Coccidioides IgG antibody titre of 1:64. Cytological samples were not available. In areas endemic for Coccidioides species, consistent clinical signs and positive antibody titres are an indication for antifungal therapy. This cat progressively improved after treatment with fluconazole, before being lost to follow-up 7 months after diagnosis

Sporotrichosis

✜ Aetiological agents Sporothrix schenckii species complex (S schenckii, S brasiliensis, S globosa, S luriei, S mexicana, S albicans).

✜ Ecological niche These fungi are found in decaying organic matter in soil or water, and dead plant matter (bark, wood, thorns, moss, etc).

✜ Geographic distribution S schenckii is distributed worldwide, especially in temperate, subtropical and tropical regions. S brasiliensis is confined to Brazil, Argentina, Chile, Panama and Paraguay (Figure 1).^103,104

✜ Transmission Routes of transmission include traumatic cutaneous inoculation of yeasts/conidia (via contaminated soil, plant foreign bodies [eg, splinters] or during fighting) and inhalation of conidia. Disease is mainly spread horizontally cat to cat through contaminated fight wounds (cat bites or scratches) in urban outbreaks in, for example, South America and Malaysia, where S brasiliensis and S schenckii, respectively, are hyperendemic.^26,105-107

✜ Clinical forms of disease Disease may occur as focal cutaneous, mucocutaneous and systemic forms.

✜ Clinical presentation Free-roaming entire male cats in urban areas are most commonly affected, presenting with multifocal, exudative, encrusted ulcers and ulcerated nodules or plaques, especially on the ear tips, nose, digits and tail base.^26,105 Mucosal involvement (nasal, conjunctival, oral and/or genital) occurs in over 30% of cases.^26,108 Nasal signs, especially sneezing, and peripheral lymphadenomegaly are common. Other ocular signs include serous discharge, blepharitis and/or uveitis.¹⁰⁸ Mucosal and cutaneous lesions can extend to involve adjacent tissues, including muscle, cartilage and bone. Primary granulomatous conjunctivitis can also occur in the absence of other lesions, characterised by epiphora, con-junctival hyperaemia and conjunctival follicles/ nodules.¹⁰⁹ Severe inflammation and thickening of the conjunctiva can produce a mass-like appearance. Haematogenous dissemination to multiple organs, especially the lungs and liver, has been described with S brasiliensis, which is more thermotolerant than S schenckii.¹⁰⁵

Dermatophytic pseudomycetoma

✜ Aetiological agents Zoophilic dermato- phytes M canis and Trichophyton mentagro-phytes (rare).

✜ Ecological niche Cats and rodents are reservoirs of M canis and T mentagrophytes, respectively.

✜ Geographic distribution These pathogens are distributed worldwide.

✜ Transmission Infectious hyphal fragments (arthroconidia) are transmitted by direct contact with an infected animal or indirectly from a contaminated environment. Derma to -phytosis develops when arthroconidia adhere to the epidermis and germinate in the stratum corneum.¹¹² Cutaneous dermatophytic pseudo-mycetoma occurs most commonly in cats with pre-existing dermatophytosis, after rupture of an infected hair follicle and release of fungal hyphae into the dermis. Contamination of the abdomen with infected hairs/hyphae or arthroconidia during surgical procedures (eg, neutering) can give rise to abdominal dermatophytic pseudomycetoma.¹¹³

✜ Clinical forms of disease Cutaneous disease is most common, but disease may also be extracutaneous.

✜ Clinical presentation Persian cats, especially spayed females over 3 years of age, are predisposed.^114-124 Genetic studies have revealed that the Persian breed has multiple single nucleotide polymorphisms (SNPs) in a gene encoding the anti microbial peptide calprotectin. These SNPs are thought to be associated with susceptibility to dermatophytosis.¹²⁵ The cutaneous form of disease is characterised by one or more soft-to-firm nodules or plaques, which may be ulcerated (Figure 13) and sometimes contain variably light-to-dark tissue grains. Depending on chron-icity, lesions range from a few millimetres to over 10 cm in diameter, and can occur anywhere on the body.

Occasionally, regional lymph nodes draining primary lesions are involved.¹ Extra-cutaneous disease may also include abdominal, nasal and oral locations.^{1,33,113,114,126} Large abdominal masses have been diagnosed months to years after ovariohysterectomy, including a uterine stump mass in one cat,¹¹⁴ and disseminated abdominal dermatophytic pseudomycetoma in another.¹¹³ Clinical signs in affected cats included constipation, tenes-mus and dysuria. Invasive fungal rhinitis with oral cavity involvement, caused by M canis, was reported in an adult cat.¹²⁶

Figure 13

Dermatophytic pseudomycetoma in a 6-year-old British Shorthair cat in Hong Kong. The cat, which had a chronic history of dermatophytosis caused by Microsporum canis, developed ulcerated masses on the tail initially, and subsequently on the trunk. Image courtesy of Dr Edmund Cheung

Aspergillosis

✜ Aetiological agents

Sino-orbital aspergillosis (SOA) - cryptic species (that look alike morphologically) in Aspergillus section Fumigati, especially A felis and A udagawae.

Disseminated invasive aspergillosis (DIA) and invasive pulmonary aspergillosis (IPA) - species in Aspergillus section Nigri and Asper-gillus section Fumigati.

✜ Ecological niche These organisms thrive in organic matter in soil.

✜ Geographic distribution They occur worldwide.

✜ Transmission Disease is tranmitted by inhalation of airborne fungal spores (conidia).

✜ Clinical forms of disease Invasive fungal rhinosinusitis, typically SOA, is most common; DIA and IPA are uncommon. Sinonasal aspergillosis, which is usually a non-invasive form of fungal rhinosinusitis,²³ is outside the scope of this review.

✜ Clinical presentation Persian cats and related breeds, including the Himalayan, Ragdoll and British Shorthair, are predisposed to SOA. Diabetes mellitus, a risk factor for invasive forms of aspergillosis in humans, has been reported in some cats with SOA and IPA.^127,128 Similar to mucormycosis, cats with DIA are usually immunocompromised (eg, from feline infectious peritonitis [FIP], FeLV infection, pan-leukopenia, immunomodulating drugs).²³

Cats with SOA are usually presented with periorbital swelling; inhaled conidia deposited in the sinonasal cavity germinate into hyphae, which invade the sinonasal mucosa causing granulomatous rhinitis, osteolysis of the orbital bone and spread of infection into the orbit. Occasionally, cats present when infection is still confined to the nasal cavity, but clinical signs at presentation are typically associated with progressive expansion of a ventromedial orbital fungal granuloma, and include unilateral exophthalmos, conjunctival hyperaemia and discharge, nictitating membrane prolapse, central corneal ulceration, an oral mass or ulcer in the ipsilateral pterygo-palatine fossa and mild mandibular lymph-adenomegaly (Figure 14). If nasal signs (eg, sneezing, discharge) are not detected at presentation, there may be a history of these over the previous 6 months. As disease progresses, exophthalmos may become bilateral and other signs may occur, including paranasal soft tissue swelling (Figure 14), which can cause severe facial distortion, and CNS signs, including seizures, nystagmus, circling, facial muscle fasciculation, hyperaesthesia and blindness. Haematogenous or lymphatic dissemination to medial retropharyngeal lymph nodes has been described in association with a ventral cervical mass in two cats.^129,130

Figure 14

Sino-orbital aspergillosis caused by Aspergillus fells infection in a 2-year-old neutered male domestic shorthair cat in Sydney, Australia. (a) The cat has exophthalmos, third eyelid prolapse and conjunctival discharge in the right eye, as well as right nasal discharge and facial distortion. (b) These signs are associated with a right orbital mass that has invaded the oral cavity, causing a bulge in the right pterygopalatine fossa (arrow)

DIA in immunosuppressed cats has been described as presenting with non-specific signs, including lethargy, anorexia, weight loss and fever. Lung and gastrointestinal involvement is most common.¹³⁰

Dematiaceous fungal infections (phaeohyphomycosis)

✜ Aetiological agents There are multiple genera of melanin-pigmented dematiaceous fungi, the most common being Alternaria, Cladophialophora, Microsphaeropsis, Lomento-spora and Exophiala species.^131-134

✜ Ecological niche These fungi can be found in soil, plants (as endophytes or pathogens) and even transiently on feline skin (Alternaria and Cladophialophora species).¹³⁵

✜ Geographic distribution While being distributed worldwide, there are regional differences in feline infections; for example, Alternaria species are most common in the UK and Europe,¹³² and Microsphaeropsis arundinis is most common in Australia.

✜ Transmission Disease is transmitted via traumatic cutaneous or ocular inoculation, or inhalation, with subsequent haematogenous dissemination.

✜ Clinical forms of disease Cutaneous disease is most common (Figure 15), but rhinosinusitis, and pulmonary and disseminated forms of disease also occur.

✜ Clinical presentation Male outdoor-roaming cats are at highest risk, but infection can occur in cats without outdoor access (eg, via inhalation). Skin lesions are single or multifocal nodules, plaques or draining tracts/non-healing wounds, especially on the pinnae, digits or nasal planum. Lesions may be poorly circumscribed and non-pigmented or dark/purplish in appearance due to melanised fungal cell walls. Multifocal lesions indicate haematogenous dissemination. Clado -phialo phora species are neurotropic and cause CNS signs often referable to cerebral or cere-bellar disease, such as seizures, circling, obtundation, ataxia and tremors. Focal lung lesions are also possible; a cat presenting to the University of Sydney with a cough was found to have a single pulmonary granuloma caused by Clado phialo phora bantiana, with no other organ involvement.⁴⁷

Figure 15

A 14-year-old female neutered domestic shorthair cat that presented with a subcutaneous mass beneath the right eye, which was identified as a pigmented mould infection. (b) On CT examination of the head, the mass was found to have invaded the right orbit

Mucormycosis and entomophthoromycosis (both previously known as zygomycosis)

✜ Aetiological agents Pathogenic moulds including Entomophthoromycetes (eg, Coni -diobolus species), Basidiobolomycetes (eg, Basi-diobolus species) and Mucoromycetes (eg, Mucor, Rhizomucor, Rhizopus and Cokeromyces species) (Table 1).

✜ Ecological niche Basidiobolus and Conidio-bolus species are soil saprophytes found in association with plant debris and are also gut commensals of amphibians, fish, reptiles and insectivorous bats.^136,137 Most other Entomoph-thoromycetes are obligate insect parasites. Mucoromycetes occur in diverse environments, including soil, water and air. Mucor species have also been detected as contaminants on healthy cats' skin, but are not commensals.¹³⁸

✜ Geographic distribution Some of these moulds are ubiquitous and occur worldwide; others (eg, Basidiobolus and Conidiobolus species) occur in tropical and subtropical regions, including Africa, Asia, Australia and South America.¹³⁶

✜ Transmission Disease is transmitted by inhalation, ingestion or inoculation of fungal spores through trauma or insect bites.¹³⁹

✜ Clinical forms of disease Gastrointestinal, pulmonary, mucocutaneous and disseminated forms of disease are recognised.

✜ Clinical presentation Entomophthoro-mycetes generally cause localised cutaneous or nasopharyngeal infections in immunocom-petent hosts.¹⁴⁰ Conidiobolomycosis and basidiobolomycosis have been reported in dogs, but not to date in cats. Mucoromycetes are typically associated with acute, rapidly progressive disease in immunocompromised hosts; for example, peritonitis caused by Cokeromyces recurvatus was reported in a cat with intestinal lymphoma-associated jejunal perforation.¹⁴¹ Disseminated mucormycosis has been diagnosed in cats with concurrent FIP, panleukopenia or FeLV infection.¹⁴² Mucor-mycosis has also been described in cats with no known comorbidities. These have included a 14-year-old domestic shorthair cat with a subcutaneous nasal mass; a 2-year-old Siamese with tracheobronchial infiltration, presenting with severe dyspnoea; and two Persian cats, both under 1 year of age, with severe nodular and ulcerative gastroduodenal infiltration, one presenting with weight loss and acute haema-temesis, and the other with weight loss, fever and abdominal distension.^143-146

Oomycoses (pythiosis, lagenidiosis and paralagenidiosis)

✜ Aetiological agents Oomycete protists in the Stramenopila-Alveolata-Rhizaria (SAR) supergroup including Pythium insidio-sum, Lagenidium species and Paralagenidium species. Their cell walls contain cellulose and beta-glucans but, unlike fungi, they do not contain chitin, nor do their cytoplasmic membranes contain ergosterol.¹⁴⁸

✜ Ecological niche These organisms are associated with soil and standing bodies of fresh water.

✜ Geographic distribution Oomycetes causing feline IFLIs occur in tropical and subtropical regions, as well as some temperate regions such as California and Arizona. Feline pythiosis has been reported in the US Gulf States (in particular Louisi-ana),^149,150 Brazil^151-154 and Spain.¹⁴⁵ The authors have also diagnosed cases in Hong Kong. Reports of pythiosis in dogs in Australia (Northern Territory, Queensland and New South Wales),^155-157 Thailand and Ma lay sia reflect the endemic presence of oomycetes.

✜ Transmission In surface water, oomy-cetes produce motile biflagellate asexual zoo spores with marked chemotactic attraction to decaying plants and to epithelial surfaces of vertebrate hosts. Infection is the result of encys-tation and invasion of damaged skin or gastrointestinal mucosa.

✜ Clinical forms of disease Cutaneous/ subcutaneous disease (Figure 16) is common, while gastrointestinal disease is uncommon. Overall, IFLIs are less common in cats than in dogs. Disease can occur at any age but cats under 12 months of age appear to be predisposed to cutaneous disease.¹⁵⁰ No other risk factors have been identified.

✜ Clinical presentation

Cutaneous/subcutaneous - Subcutaneous masses are seen, especially in the neck, trunk, inguinal and perianal areas, nasopharynx and / or sino-orbitally. Sometimes these lesions are ulcerated with multiple fistulous tracts. They also occur at the tail base or extremities. Perianal lesions may present as a subcutaneous mass encircling the anus and can extend intrapelvically.

Gastrointestinal pythiosis - Small intestinal masses develop, with mesenteric lymph node involvement.¹⁴⁴,¹⁴⁹,¹⁵²,¹⁵⁴ Presenting signs include combinations of anorexia, vomiting, haema-temesis, diarrhoea and weight loss. Palpable abdominal mass(es) may be present and, owing to the insidious course of disease, may be very large (>10 cm diameter) at presentation.

Figure 16

(a) An 8-month-old female domestic shorthair cat, which had been adopted as a stray in Hong Kong, developed firm, progressive swelling of the right hind leg. (b) A CT scan taken by the primary veterinarian showed diffuse subcutaneous tissue infiltrates with increased soft tissue attenuation. (c) The affected tissue was surgically debulked at the time that diagnostic biopsies were collected. Histopathology revealed granulomatous inflammatory tissue containing irregular fungal hyphae. These were identified by PCR as Pythium insidiosum. Images courtesy of Dr Edmund Cheung

Key Points

✜ Invasive fungal and fungal-like infections in cats most commonly present with cutaneous, subcutaneous and/or respiratory signs, but in disseminated disease can have a variety of different clinical presentations, depending on organ involvement.

✜ These infections should be on clinicians' diagnostic radars and can be definitively diagnosed using a combination of different techniques that are readily accessible in clinical practice.

Footnotes

Acknowledgements

The authors would like to thank Dr Edmund Cheung, from Non-Profit Making Veterinary Services, Prince Edward, Hong Kong, for contributing some of the images in this article.

Conflict of interest

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

This article was funded by a grant (SGP 9380113) from City University of Hong Kong to one of the authors (VRB).

Ethical approval

This work did not involve the use of animals and therefore ethical approval was not specifically required for publication in JFMS.

Informed consent

This work did not involve the use of animals (including cadavers) and therefore informed consent was not required. No animals or people are identifiable within this publication, and therefore additional informed consent for publication was not required.

References

Chang

Liao

Shyu

, et al. Dermatophytic pseu-domycetomas in four cats. Vet Dermatol 2011; 22: 181-187.

Miller

Albert

RA.

Ocular and systemic candidiasis in a cat. J Am Anim Hosp Assoc 1988; 24: 521-524.

Duchaussoy

Rose

Talbot

, et al. Gastrointestinal granuloma due to Candida albicans in an immunocompetent cat. Med Mycol Case Rep 2015; 10: 14-17.

Gerding

Jr Morton

Dye

JA.

Ocular and disseminated candidiasis in an immunosuppressed cat. J Am Vet Med Assoc 1994; 204: 1635-1638.

Lamm

Grune

Estrada

, et al. Granulomatous rhinitis due to Candida parapsilosis in a cat. J Vet Diagn Invest 2013; 25: 596-598.

Renner

Hill

Grinberg

, et al. Pancreatic candidiasis in a cat. JFMS Open Rep 2021; 7. DOI: 10.1177/20551169211052889.

Reagan

Dear

Kass

, et al. Risk factors for Candida urinary tract infections in dogs and cats. J Vet Intern Med 2019; 33: 648-653.

Kessell

McNair

Munday

, et al. Successful treatment of multifocal pedal Prototheca wickerhamii infection in a feline immunodeficiency virus-positive cat with multiple Bowenoid in situ carcinomas containing papillomaviral DNA sequences. JFMS Open Rep 2017; 3. DOI: 10.1177/2055116916688590.

Maboni

Elbert

Stilwell

, et al. Genomic and pathologic findings for Prototheca cutis infection in cat. Emerg Infect Dis 2021; 27: 979-982.

10.

Ely

Espindola

Barasuol

, et al. Protothecosis in veterinary medicine: a minireview. Lett Appl Microbiol 2023; 76. DOI: 10.1093/lambio/ovad066.

11.

Masuda

Jagielski

Danesi

, et al. Protothecosis in dogs and cats - new research directions. Mycopathologia 2021; 186: 143-152.

12.

Huth

Wenkel

Roschanski

, et al. Prototheca zopfii genotype 2-induced nasal dermatitis in a cat. J Comp Pathol 2015; 152: 287-290.

13.

Endo

Sekiguchi

Kishimoto

, et al. The first case of feline Prototheca wickerhamii infection in Japan. J Vet Med Sci 2010; 72: 1351-1353.

14.

Coloe

Allison

JF.

Protothecosis in a cat. J Am Vet Med Assoc 1982; 180: 78-79.

15.

Kaplan

Chandler

Holzinger

, et al. Protothecosis in a cat: first recorded case. Sabouraudia 1976; 14: 281-286.

16.

Finnie

Coloe

PJ.

Cutaneous protothecosis in a cat. Aust Vet J 1981; 57: 307-308.

17.

Addie

Tasker

Boucraut-Baralon

, et al. Encephalitozoon cuniculi infection in cats: European guidelines from the ABCD on prevention and management. J Feline Med Surg 2020; 22: 1084-1088.

18.

Barrs

Hobi

Wong

, et al. Invasive fungal infections and oomycoses in cats: 2. Antifungal therapy. J Feline Med Surg 2024; 26. DOI: 10.1177/1098612X231220047.

19.

Voigt

James

Kirk

, et al. Early-diverging fungal phyla: taxonomy, species concept, ecology, distribution, anthropogenic impact, and novel phylogenetic proposals. Fungal Divers 2021; 109: 59-98.

20.

Kidd

Abdolrasouli

Hagen

Fungal nomenclature: managing change is the name of the game. Open Forum Infect Dis 2023; 10. DOI: 10.1093/ofid/ofac559.

21.

Mazi

Sahrmann

Olsen

, et al. The geographic distribution of dimorphic mycoses in the United States for the modern era. Clin Infect Dis 2023; 76: 1295-1301.

22.

Klang

Loncaric

Spergser

, et al. Disseminated histoplas-mosis in a domestic cat imported from the USA to Austria. Med Mycol Case Rep 2013; 2: 108-112.

23.

Barrs

Talbot

JJ.

Fungal rhinosinusitis and disseminated invasive aspergillosis in cats. Vet Clin North Am Small Anim Pract 2020; 50: 331-357.

24.

Dedeaux

Grooters

Wakamatsu-Utsuki

, et al. Opportunistic fungal infections in small animals. J Am Anim Hosp Assoc 2018; 54: 327-337.

25.

Barrs

Halliday

Martin

, et al. Sinonasal and sino-orbital aspergillosis in 23 cats: aetiology, clinicopathological features and treatment outcomes. Vet J 2012; 191: 58-64.

26.

Schubach

Okamoto

, et al. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). J Am Vet Med Assoc 2004; 224: 1623-1629.

27.

Malik

Wigney

Muir

, et al. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992; 30: 133-144.

28.

Fielder

Meinkoth

Rizzi

, et al. Feline histoplasmo-sis presenting with bone and joint involvement: clinical and diagnostic findings in 25 cats. J Feline Med Surg 2019; 21: 887-892.

29.

Wolf

AM.

Histoplasma capsulatum osteomyelitis in the cat. J Vet Intern Med 1987; 1: 158-162.

30.

Arbona

Butkiewicz

Keyes

, et al. Clinical features of cats diagnosed with coccidioidomycosis in Arizona, 2004-2018. J Feline Med Surg 2020; 22: 129-137.

31.

Aulakh

Troy

Feline histoplasmosis: a retrospective study of 22 cases (1986-2009). J Am Anim Hosp Assoc 2012; 48: 182-187.

32.

Stern

Chew

Schissler

, et al. Cutaneous and systemic blastomycosis, hypercalcemia, and excess synthesis of calcitriol in a domestic shorthair cat. J Am Anim Hosp Assoc 2011; 47: e116-e120.

33.

Zafrany

Ben-Oz

Segev

, et al. Successful treatment of an intra-pelvic fungal pseudomycetoma causing constipation and hypercalcaemia in a Persian cat. J Feline Med Surg 2014; 16: 369-372.

34.

Barrs

Ujvari

Dhand

, et al. Detection of Aspergillus-specific antibodies by agar gel double immunodiffusion and IgG ELISA in feline upper respiratory tract aspergillosis. Vet J 2015; 203: 285-289.

35.

Taylor

Peters

Dhand

, et al. Evaluation of serum Aspergillus-specific immunoglobulin A by indirect ELISA for diagnosis of feline upper respiratory tract aspergillosis. J Vet Intern Med 2016; 30: 1708-1714.

36.

Whitney

Beatty

Martin

, et al. Evaluation of serum galactomannan detection for diagnosis of feline upper respiratory tract aspergillosis. Vet Microbiol 2013; 162: 180-185.

37.

Fernandes

Lopes-Bezerra

Bernardes-Engemann

, et al. Serodiagnosis of sporotrichosis infection in cats by enzyme-linked immunosorbent assay using a specific antigen, SsCBF, and crude exoantigens. Vet Microbiol 2011; 147: 445-449.

38.

Cook

Cunningham

Cowell

, et al. Clinical evaluation of urine Histoplasma capsulatum antigen measurement in cats with suspected disseminated histoplasmosis. J Feline Med Surg 2012; 14: 512-515.

39.

Hanzlicek

Meinkoth

Renschler

, et al. Antigen concentrations as an indicator of clinical remission and disease relapse in cats with histoplasmosis. J Vet Intern Med 2016; 30: 1065-1073.

40.

Teixeira

Dubielzig

RR.

Feline ocular histoplasmosis, comparison with human presumed ocular histoplasmosis syndrome (POHS). Invest Ophthalmol Vis Sci 2010; 51: 6326.

41.

Greene

Troy

GC.

Coccidioidomycosis in 48 cats: a retrospective study (1984-1993). J Vet Intern Med 1995; 9: 86-91.

42.

Graupmann-Kuzma

Valentine

Shubitz

, et al. Coccidioidomycosis in dogs and cats: a review. J Am Anim Hosp Assoc 2008; 44: 226-235.

43.

Kirsch

Greene

Prahl

, et al. Evaluation of Coccidioides antigen detection in dogs with coccidioido-mycosis. Clin Vaccine Immunol 2012; 19: 343-345.

44.

Medleau

Marks

Brown

, et al. Clinical evaluation of a cryptococcal antigen latex agglutination test for diagnosis of cryptococcosis in cats. J Am Vet Med Assoc 1990; 196: 1470-1473.

45.

Reagan

McHardy

Thompson

3rd , et al. Evaluation of the clinical performance of 2 point-of-care cryptococcal antigen tests in dogs and cats. J Vet Intern Med 2019; 33: 2082-2089.

46.

Hartfield

Grooters

Waite

KJ.

Development and evaluation of an ELISA for the quantitation of anti-Lagenidium giganteum forma caninum antibodies in dogs. J Vet Intern Med 2014; 28: 1479-1484.

47.

Evans

Gunew

Marshall

, et al. Focal pulmonary gran-uloma caused by Cladophialophora bantiana in a domestic short haired cat. Med Mycol 2011; 49: 194-197.

48.

Gilor

Graves

Barger

, et al. Clinical aspects of natural infection with Blastomyces dermatitidis in cats: 8 cases (1991-2005). J Am Vet Med Assoc 2006; 229: 96-99.

49.

Trivedi

Malik

Meyer

, et al. Feline cryptococcosis: impact of current research on clinical management. J Feline Med Surg 2011; 13: 163-172.

50.

Wolf

Green

RW.

The radiographic appearance of pulmonary histoplasmosis in the cat. Vet Radiol Ultrasound 1987; 28: 34-37.

51.

Barrs

Beatty

Dhand

, et al. Computed tomo- graphic features of feline sino-nasal and sino-orbital aspergillosis. Vet J 2014; 201: 215-222.

52.

Bissonnette

Sharp

Dkystra

MHJ

, et al. Nasal and retrobulbar mass in a cat caused by Pythium insidiosum. J Med Vet Mycol 1991; 29: 39-44.

53.

Barachetti

Mortellaro

Di Giancamillo

, et al. Bilateral orbital and nasal aspergillosis in a cat. Vet Ophthalmol 2009; 12: 176-182.

54.

Giordano

Gianella

, et al. Invasive mould infections of the naso-orbital region of cats: a case involving Aspergillus fumigatus and an aetiological review. J Feline Med Surg 2010; 12: 714-723.

55.

Smith

Hoffman

SB.

A case series of unilateral orbital aspergillosis in three cats and treatment with voriconazole. Vet Ophthalmol 2010; 13: 190-203.

56.

Hecht

Michaels

Simon

Case report: MRI findings with CNS blastomycosis in three domestic cats. Front Vet Sci 2022; 9. DOI: 10.3389/fvets.2022.966853.

57.

Luthra

Parihar

Nath

, et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007; 28: 1332-1338.

58.

Bentley

Taylor

Thomovsky

SA.

Fungal infections of the central nervous system in small animals: clinical features, diagnosis, and management. Vet Clin North Am Small Anim Pract 2018; 48: 63-83.

59.

Sykes

Sturges

Cannon

, et al. Clinical signs, imaging features, neuropathology, and outcome in cats and dogs with central nervous system cryptococcosis from California. J Vet Intern Med 2010; 24: 1427-1438.

60.

Bentley

Heng

Thompson

, et al. Magnetic resonance imaging features and outcome for solitary central nervous system Coccidioides granulomas in 11 dogs and cats. Vet Radiol Ultrasound 2015; 56: 520-530.

61.

Borman

Mohammed

Palmer

, et al. The importance of appropriate processing and direct microscopic examination for the timely diagnosis and management of invasive infections caused by filamentous fungi. Med Mycol 2022; 60. DOI: 10.1093/mmy/myac081.

62.

Richardson

Warnock

DW.

Laboratory diagnosis of fungal infection. In: Richardson

Warnock

(eds). Fungal infection: diagnosis and management. 4th ed. Wiley-Blackwell, 2012, pp 12-31.

63.

Kidd

Halliday

Ellis

Descriptions of medical fungi. 4th ed. Wallingford, UK: CABI, 2022.

64.

Hong

Miller

Allgood

, et al. Use of selective fungal culture media increases rates of detection of fungi in the respiratory tract of cystic fibrosis patients. J Clin Microbiol 2017; 55: 1122-1130.

65.

Hubka

Barrs

Dudova

, et al. Unravelling species boundaries in the Aspergillus viridinutans complex (section Fumigati): opportunistic human and animal pathogens capable of interspecific hybridization. Persoonia 2018; 41: 142-174.

66.

Lau

Chen

Sorrell

, et al. Development and clinical application of a panfungal PCR assay to detect and identify fungal DNA in tissue specimens. J Clin Microbiol 2007; 45: 380-385.

67.

Meason-Smith

Edwards

Older

, et al. Panfungal polymerase chain reaction for identification of fungal pathogens in formalin-fixed animal tissues. Vet Pathol 2017; 54: 640-648.

68.

Lyskova

Hubka

Svobodova

, et al. Antifungal susceptibility of the Aspergillus viridinutans complex: comparison of two in vitro methods. Antimicrob Agents Chemother 2018; 62. DOI: 10.1128/aac.01927-17.

69.

Talbot

Frisvad

Meis

, et al. cyp51A mutations, extro-lite profiles, and antifungal susceptibility in clinical and environmental isolates of the Aspergillus viridinutans species complex. Antimicrob Agents Chemother 2019; 63. DOI: 10.1128/aac.00632-19.

70.

Hagen

Khayhan

Theelen

, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol 2015; 78: 16-48.

71.

Hagen

Lumbsch

Arsic Arsenijevic

, et al. Importance of resolving fungal nomenclature: the case of multiple pathogenic species in the Cryptococcus genus. mSphere 2017; 2. DOI: 10.1128/mSphere.00238-17.

72.

Nielsen

Obaldia

ALD

Heitman

Cryptococcus neofor-mans mates on pigeon guano: implications for the realized ecological niche and globalization. Eukaryotic Cell 2007; 6: 949-959.

73.

Hagen

Boekhout

The search for the natural habitat of

Cryptococcus gattii. Mycopathologia 2010; 170: 209-211.

74.

Reis

Bonna

ICF

Antonio

IMDS

, et al. Cryptococcus neoformans VNII as the main cause of cryptococcosis in domestic cats from Rio de Janeiro, Brazil. J Fungi (Basel) 7. DOI: 10.3390/jof7110980.

75.

Berry

Van Rensburg

Henton

MM.

Systemic cryptococcosis in a cat. J S Afr Vet Assoc 1990; 61: 71-76.

76.

Martins

Zanette

Franca

, et al. Massive crypto-coccal disseminated infection in an immunocompetent cat. Vet Dermatol 2011; 22: 232-234.

77.

Medleau

Hall

Goldschmidt

, et al. Cutaneous cryptococcosis in three cats. J Am Vet Med Assoc 1985; 187: 169-170.

78.

Beatty

Barrs

Swinney

, et al. Peripheral vestibular disease associated with cryptococcosis in three cats. J Feline Med Surg 2000; 2: 29-34.

79.

Barrs

Martin

Nicoll

, et al. Pulmonary cryptococcosis and Capillaria aerophila infection in an FIV-positive cat. Aust Vet J 2000; 78: 154-158.

80.

Meadows

MacWilliams

Dzata

, et al. Chylothorax associated with cryptococcal mediastinal granuloma in a cat. Vet Clin Pathol 1993; 22: 109-116.

81.

Jacobson

Morton

Woerde

, et al. Clinical features, outcomes, and long-term survival times of cats and dogs with central nervous system cryptococcosis in Australia: 50 cases (2000-2020). J Am Vet Med Assoc 2022; 261: 246-257.

82.

Cogliati

Global warming impact on the expansion of fundamental niche of Cryptococcus gattii VGI in Europe. Environ Microbiol Rep 2021; 13: 375-383.

83.

Lyon

Bravo

Espino

, et al. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. Am J Trop Med Hyg 2004; 70: 438-442.

84.

Gomez

Torres

Jimenez

, et al. Detection of Histoplasma capsulatum in organic fertilizers by Hc100 nested polymerase chain reaction and its correlation with the physicochemical and microbiological characteristics of the samples. Am J Trop Med Hyg 2018; 98: 1303-1312.

85.

Kauffman

CA.

Histoplasmosis. Clin Chest Med 2009; 30: 217-225.

86.

Blass

Histoplasmosis in a cat

[Histoplasma capsulatum]. J Am Anim Hosp Assoc 1982; 18: 468-470.

87.

Davies

Troy

GC.

Deep mycotic infections in cats. J Am Anim Hosp Assoc 1996; 32: 380-391.

88.

Hodges

Legendre

Adams

, et al. Itraconazole for the treatment of histoplasmosis in cats. J Vet Intern Med 1994; 8: 409-413.

89.

Ludwig

Hanzlicek

KuKanich

, et al. Candidate prognostic indicators in cats with histoplasmosis treated with antifungal therapy. J Feline Med Surg 2017; 20: 985-996.

90.

Aronson

Bendickson

Miles

, et al. Disseminated histoplasmosis with osseous lesions in a cat with feline lymphosarcoma. Vet Radiol 1986; 27: 50-53.

91.

Gabbert

Campbell

Beiermann

Pancytopenia associated with disseminated histoplasmosis in a cat. J Am Anim Hosp Assoc 1984; 20: 119-122.

92.

Percy

DH.

Feline histoplasmosis with ocular involvement. Vet Pathol 1981; 18: 163-169.

93.

Smith

Strom

Gilmour

, et al. Utility of antigen testing for the diagnosis of ocular histoplasmosis in four cats: a case series and literature review. J Feline Med Surg 2017; 19: 1110-1118.

94.

Hagan

The discovery and naming of histoplasmosis: Samuel Taylor Darling. JAMA 1903; 40: 1905-1907.

95.

Blischok

Bender

What is your diagnosis? 15-year-old male domestic shorthair cat with disseminated histoplasmosis. Vet Clin Pathol 1996; 25: 113-152.

96.

Rochat

Crystal

Challenging cases in internal medicine: what's your diagnosis?

Vet Med 1999; 94: 520.

97.

Blondin

Baumgardner

Moore

, et al. Blastomycosis in indoor cats: suburban Chicago, Illinois, USA. Mycopathologia 2007; 163: 59-66.

98.

Jackson

Pelletier

Scheftel

, et al. Analysis and modeling of Blastomyces dermatitidis environmental prevalence in Minnesota using soil collected to compare basal and outbreak levels. Appl Environ Microbiol 2021; 87. DOI: 10.1128/aem.01922-20.

99.

Morris

Sigmund

Ward

, et al. Ocular findings in cats with blastomycosis: 19 cases (1978-2019). J Am Vet Med Assoc 2021; 260: 422-427.

100.

Liang

Shen

, et al. Coccidioidomycosis: imported and possible domestic cases in China: a case report and review, 1958-2017. Mycoses 2018; 61: 506-513.

101.

Simoes

Dial

Coyner

, et al. Retrospective analysis of cutaneous lesions in 23 canine and 17 feline cases of coccidioidomycosis seen in Arizona, USA (2009-2015). Vet Dermatol 2016; 27: 346-e387.

102.

Dowdy

Evans

Jaffey

, et al. Case report: successful management of a compressive intraspinal Coccidioides species granuloma in a cat. Front Vet Sci 2021; 8. DOI: 10.3389/fvets.2021.801885.

103.

Thomson

Gonzalez

Blank

, et al. Sporotrichosis outbreak due to Sporothrix brasiliensis in domestic cats in Magallanes, Chile: a One Health-approach study. J Fungi (Basel) 2023; 9. DOI: 10.3390/jof9020226.

104.

Rossow

Queiroz-Telles

Caceres

, et al. A One Health approach to combatting Sporothrix brasiliensis: narrative review of an emerging zoonotic fungal pathogen in South America. J Fungi (Basel) 2020; 6. DOI: 10.3390/jof6040247.

105.

Han

Kano

Feline sporotrichosis in Asia. Braz J Microbiol 2021; 52: 125-134.

106.

Siew

HH.

The current status of feline sporotrichosis in Malaysia. Med Mycol J 2017; 58: e107-e113.

107.

Tang

Gill

, et al. Cutaneous sporotrichosis: a six-year review of 19 cases in a tertiary referral center in Malaysia. Int J Dermatol 2012; 51: 702-708.

108.

Freitas

da Rocha

RCB

de Farias

, et al. Ocular lesions in cats diagnosed with systemic sporotrichosis. Vet Ophthalmol 2023; 26: 476-488.

109.

Spinelli

Bezerra

de Souza

BOF

, et al. Primary conjunctival sporotrichosis in three cats from Northeastern Brazil. Vet Ophthalmol 2021; 24: 209-215.

110.

Silva

Miranda

LHM

Menezes

, et al. Comparison of the sensitivity of three methods for the early diagnosis of sporotrichosis in cats. J Comp Pathol 2018; 160: 72-78.

111.

Pereira

Menezes

Gremiao

, et al. Sensitivity of cytopathological examination in the diagnosis of feline sporotrichosis. J Feline Med Surg 2011; 13: 220-223.

112.

Moskaluk

VandeWoude

Current topics in der-matophyte classification and clinical diagnosis. Pathogens 2022; 11. DOI: 10.3390/pathogens11090957.

113.

Bianchi

Laisse

CJM

Vargas

, et al. Intra-abdominal fungal pseudomycetoma in two cats. Rev Iberoam Micol 2017; 34: 112-115.

114.

Black

Abemethy

Tyler

, et al. Intra-abdominal dermatophytic pseudomycetoma in a Persian cat. J Vet Intern Med 2001; 15: 245-248.

115.

Bond

Pocknell

Toze

Pseudomycetoma caused by Microsporum canis in a Persian cat: lack of response to oral terbinafine. J Small Anim Pract 2001; 42: 557-560.

116.

Kano

Edamura

Yumikura

, et al. Confirmed case of feline mycetoma due to Microsporum canis. Mycoses 2009; 52: 80-83.

117.

Medleau

Rakich

PM.

Microsporum canis pseudomyce-tomas in a cat. J Am Anim Hosp Assoc 1994; 30: 573-576.

118.

Miller

Goldschmidt

Mycetomas in the cat caused by a dermatophyte - a case report. J Am Vet Med Assoc 1986; 22: 255-260.

119.

Nuttall

German

Holden

, et al. Successful resolution of dermatophyte mycetoma following terbinafine treatment in two cats. Vet Dermatol 2008; 19: 405-410.

120.

Tuttle

Chandler

Deep dermatophytosis in a cat. J Am Vet Med Assoc 1983; 183: 1106-1108.

121.

Yager

Wilcock

Lynch

, et al. Mycetoma-like granuloma in a cat caused by Microsporum canis. J Comp Pathol 1986; 96: 171-176.

122.

Zimmerman

Feldman

Robertson

, et al. Dermal mass aspirate from a Persian cat. Vet Clin Pathol 2003; 32: 213-217.

123.

Duangkaew

Larsuprom

Kasondorkbua

, et al. Cutaneous blastomycosis and dermatophytic pseudomyce-toma in a Persian cat from Bangkok, Thailand. Med Mycol Case Rep 2017; 15: 12-15.

124.

Pereira

Damico

de Souza

HJM

, et al. Dermatophytic pseudomycetoma caused by Microsporum canis in Persian cats [article in Portuguese]. Acta Scientiae Veterinariae 2006; 34: 193-196.

125.

Myers

Lawhon

Diesel

, et al. An ancient haplotype containing antimicrobial peptide gene variants is associated with severe fungal skin disease in Persian cats. PLoS Genet 2022; 18. DOI: 10.1371/journal.pgen.1010062.

126.

Ziglioli

Panciera

LeRoith

, et al. Invasive Microsporum canis causing rhinitis and stomatitis in a cat. J Small Anim Pract 2016; 57: 327-331.

127.

Kano

Takahashi

Hayakawa

, et al. The first case of feline sinonasal aspergillosis due to Aspergillus fischeri in Japan. J Vet Med Sci 2015; 77: 1183-1185.

128.

Hazell

Swift

Sullivan

Successful treatment of pulmonary aspergillosis in a cat. Aust Vet J 2011; 89: 101-104.

129.

Cormack

Donahoe

Talbot

, et al. Disseminated invasive aspergillosis caused by Aspergillus felis in a cat. J Vet Intern Med 2021; 35: 2395-2400.

130.

Bartels

Alvarez-Sanchez

Ranganathan

, et al. Ventral cervical subcutaneous Aspergillus species fungal granuloma in a cat. JFMS Open Rep 2022; 8. DOI: 10.1177/20551169221121916.

131.

Dye

Johnson

Gruffydd-Jones

TJ.

Alternaria species infection in nine domestic cats. J Feline Med Surg 2009; 11: 332-336.

132.

Reppas

Gottleib

Krockenberger

, et al. Micro sphaeropsis arundinis: an emerging cause of phaeo-hyphomycosis in cats and people. Microbiol Aust 2015; 36: 74-78.

133.

Kettlewell

McGinnis

Wilkinson

Phaeohyphomycosis caused by Exophiala spinifera in two cats. J Med Vet Mycol 1989; 27: 257-264.

134.

Chermette

Ferreiro

De Bievre

, et al. Exophiala spinifera nasal infection in a cat and a literature review of feline phaeohyphomycoses. J Mycol Med 1997; 7: 149-158.

135.

Meason-Smith

Diesel

Patterson

, et al. Characterization of the cutaneous mycobiota in healthy and allergic cats using next generation sequencing. Vet Dermatol 2017; 28: 71-e17.

136.

Richardson

The ecology of the Zygomycetes and its impact on environmental exposure. Clin Microbiol Infect 2009; 15: 2-9.

137.

Flagothier

Arrese

Quatresooz

, et al. Cutaneous mucor-mycosis. J Mycol Med 2006; 16: 77-81.

138.

Khosravi

AR.

Fungal flora of the hair coat of stray cats in Iran. Mycoses 1996; 39: 241-243.

139.

Bouza

Munoz

Guinea

Mucormycosis: an emerging disease?

Clin Microbiol Infect 2006; 12: 7-23.

140.

Prabhu

Patel

Mucormycosis and entomophtho- ramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004; 10: 31-47.

141.

Nielsen

Sutton

Matise

, et al. Isolation of Cokero-myces recurvatus, initially misidentified as Coccidioides immitis, from peritoneal fluid in a cat with jejunal perforation. J Vet Diagn Invest 2005; 17: 372-378.

142.

Ossent

Systemic aspergillosis and mucormycosis in 23 cats. Vet Rec 1987; 120: 330-333.

143.

Wray

Sparkes

Johnson

EM.

Infection of the subcutis of the nose in a cat caused by Mucor species: successful treatment using posaconazole. J Feline Med Surg 2008; 10: 523-527.

144.

Grau-Roma

Galindo-Cardiel

Isidoro-Ayza

, et al. A case of feline gastrointestinal eosinophilic sclerosing fibroplasia associated with phycomycetes. J Comp Pathol 2014; 151: 318-321.

145.

Cunha

Aguero

Damico

, et al. Duodenal perforation caused by Rhizomucor species in a cat. J Feline Med Surg 2011; 13: 205-207.

146.

Snyder

Spaulding

Edwards

Imaging diagnosis - tracheobronchial zygomycosis in a cat. Vet Radiol Ultrasound 2010; 51: 617-620.

147.

Dehghanpir

SD.

Cytomorphology of deep mycoses in dogs and cats. Vet Clin North Am Small Anim Pract 2023; 53: 155-173.

148.

Gaastra

Lipman

De Cock

, et al. Pythium insidio-sum: an overview. Vet Microbiol 2010; 146: 1-16.

149.

Rakich

Grooters

Tang

KN.

Gastrointestinal pythiosis in two cats. J Vet Diagn Invest 2005; 17: 262-269.

150.

Grooters

AM.

Pythiosis, lagenidiosis, and zygomycosis in small animals. Vet Clin North Am Small Anim Pract 2003; 33: 695-720.

151.

de Souto

EPF

Kommers

Souza

, et al. A retrospective study of pythiosis in domestic animals in northeastern Brazil. J Comp Pathol 2022; 195: 34-50.

152.

Souto

EPF

Maia

Virginio

, et al. Pythiosis in cats in northeastern Brazil. J Mycol Med 2020; 30: DOI: 10.1016/j.mycmed.2020.101005.

153.

Soares

LMC

Schenkel

Rosa

JMA

, et al. Feline subcutaneous pythiosis. Ciencia Rural 2019; 49. DOI: 10.1590/0103-8478cr20180448.

154.

Galiza

GJN

da Silva

Caprioli

, et al. Occurrence of mycoses and pythiosis in domestic animals: 230 cases. Pesqui Vet Bras 2014; 34: 224-232.

155.

Miller

Campbell

RSF

. The comparative pathology of equine cutaneous phycomycosis. Vet Pathol 1984; 21: 325-332.

156.

English

Frost

AJ.

Phycomycosis in a dog. Aust Vet J 1984; 61: 291-292.

157.

Krockenberger

Swinney

Martin

, et al. Sequential opportunistic infections in two German Shepherd dogs. Aust Vet J 2011; 89: 9-14.

158.

De Cock

Mendoza

Padhye

, et al. Pythium insidio-sum sp. nov., the etiologic agent of pythiosis. J Clin Microbiol 1987; 25: 344-349.

Invasive fungal infections and oomycoses in cats: 1. Diagnostic approach

Abstract

Clinical relevance:

Aim:

Evidence base:

Keywords

Introduction

Agents of disease

General diagnostic approach to a possible invasive fungal or fungal-like infection

History and signalment

Complete blood count, serum biochemistry profile and retrovirus testing

Fungal-specific tests on urine, serum or other body fluids

Diagnostic imaging

Cytology

Surgical biopsies: procurement and transport to the laboratory

Fungal culture

Optimal conditions for culture

Molecular diagnostics

Antifungal susceptibility testing

Diagnostic approach for selected invasive fungal and fungal-like infections

Cryptococcosis

Histoplasmosis

Blastomycosis

Coccidioidomycosis

Sporotrichosis

Dermatophytic pseudomycetoma

Aspergillosis

Dematiaceous fungal infections (phaeohyphomycosis)

Mucormycosis and entomophthoromycosis (both previously known as zygomycosis)

Oomycoses (pythiosis, lagenidiosis and paralagenidiosis)

Key Points

Footnotes

Acknowledgements

Conflict of interest

Funding

Ethical approval

Informed consent

References